{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:38:53Z","timestamp":1777505933615,"version":"3.51.4"},"reference-count":31,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increased fibrinolysis is an important component of acute promyelocytic leukemia (APL) bleeding diathesis. APL blasts overexpress annexin II (ANXII), a receptor for tissue plasminogen activator (tPA), and plasminogen, thereby increasing plasmin generation. Previous studies suggested that ANXII plays a pivotal role in APL coagulopathy. ANXII binding to tPA can be inhibited by homocysteine and hyperhomocysteinemia can be induced by L-methionine supplementation. In the present study, we used an APL mouse model to study ANXII function and the effects of hyperhomocysteinemia in vivo. Leukemic cells expressed higher ANXII and tPA plasma levels (11.95 ng\/mL in leukemic vs 10.74 ng\/mL in wild-type; P = .004). In leukemic mice, administration of L-methionine significantly increased homocysteine levels (49.0 \u03bcmol\/mL and &lt; 6.0 \u03bcmol\/mL in the treated and nontreated groups, respectively) and reduced tPA levels to baseline concentrations. The latter were also decreased after infusion of the LCKLSL peptide, a competitor for the ANXII tPA\u2013binding site (11.07 ng\/mL; P = .001). We also expressed and purified the p36 component of ANXII in Pichia methanolica. The infusion of p36 in wild-type mice increased tPA and thrombin-antithrombin levels, and the latter was reversed by L-methionine administration. The results of the present study demonstrate the relevance of ANXII in vivo and suggest that methionine-induced hyperhomocysteinemia may reverse hyperfibrinolysis in APL.<\/jats:p>","DOI":"10.1182\/blood-2011-04-347187","type":"journal-article","created":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T00:32:07Z","timestamp":1334881927000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia"],"prefix":"10.1182","volume":"120","author":[{"given":"Rafael H.","family":"J\u00e1como","sequence":"first","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"},{"name":"Laborat\u00f3rio Sabin, Bras\u00edlia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Santana-Lemos","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Silvia G.","family":"Lima","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Assis","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula A.","family":"Lange","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena L.","family":"Figueiredo-Pontes","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana O.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Bassi","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana T. L.","family":"Ben\u00edcio","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia S.","family":"Baggio","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aglair B.","family":"Garcia","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto P.","family":"Falc\u00e3o","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo M.","family":"Rego","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology\/Hematology, Department of Internal Medicine, Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"15","key":"2019111807543451700_B1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","article-title":"All-trans-retinoic acid in acute promyelocytic leukemia.","volume":"337","author":"Tallman","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111807543451700_B2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/1097-0142(19850101)55:1<18::AID-CNCR2820550104>3.0.CO;2-B","article-title":"Acute promyelocytic leukemia in 57 previously untreated patients.","volume":"55","author":"Cordonnier","year":"1985","journal-title":"Cancer"},{"issue":"10","key":"2019111807543451700_B3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3324\/haematol.10874","article-title":"Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.","volume":"92","author":"J\u00e1como","year":"2007","journal-title":"Haematologica"},{"issue":"25","key":"2019111807543451700_B4","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1182\/blood-2010-01-266007","article-title":"Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.","volume":"115","author":"Sanz","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111807543451700_B5","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood.V84.9.3001.3001","article-title":"All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells.","volume":"84","author":"Koyama","year":"1994","journal-title":"Blood"},{"issue":"7","key":"2019111807543451700_B6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2401448","article-title":"Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.","volume":"13","author":"Zhu","year":"1999","journal-title":"Leukemia"},{"issue":"4","key":"2019111807543451700_B7","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V70.4.1218.1218","article-title":"Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors.","volume":"70","author":"Griffin","year":"1987","journal-title":"Blood"},{"issue":"2","key":"2019111807543451700_B8","first-page":"126","article-title":"Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia.","volume":"15","author":"Sterrenberg","year":"1985","journal-title":"Haemostasis"},{"issue":"9","key":"2019111807543451700_B9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood.V77.9.1949.1949","article-title":"The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.","volume":"77","author":"Sakata","year":"1991","journal-title":"Blood"},{"issue":"2","key":"2019111807543451700_B10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI108784","article-title":"The behavior of alpha2-plasmin inhibitor in fibrinolytic states.","volume":"60","author":"Aoki","year":"1977","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111807543451700_B11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2141.2000.01890.x","article-title":"Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia.","volume":"108","author":"Meijers","year":"2000","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111807543451700_B12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2141.1989.tb06311.x","article-title":"The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination.","volume":"71","author":"Bennett","year":"1989","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111807543451700_B13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood.V82.3.914.914","article-title":"Abundant urokinase activity on the surface of mononuclear cells from blood and bone marrow of acute leukemia patients.","volume":"82","author":"Tapiovaara","year":"1993","journal-title":"Blood"},{"issue":"13","key":"2019111807543451700_B14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJM199904013401303","article-title":"Annexin II and bleeding in acute promyelocytic leukemia.","volume":"340","author":"Menell","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111807543451700_B15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0049-3848(02)00075-0","article-title":"Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen\/tissue plasminogen activator.","volume":"106","author":"Zhang","year":"2002","journal-title":"Thromb Res"},{"issue":"1-2","key":"2019111807543451700_B16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2004.07.014","article-title":"Annexin II cell surface and mRNA expression in human acute myeloid leukaemia cell lines.","volume":"115","author":"Olwill","year":"2005","journal-title":"Thromb Res"},{"issue":"33","key":"2019111807543451700_B17","doi-asserted-by":"crossref","first-page":"21198","DOI":"10.1016\/S0021-9258(17)31948-8","article-title":"An endothelial cell receptor for plasminogen\/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.","volume":"269","author":"Cesarman","year":"1994","journal-title":"J Biol Chem"},{"issue":"33","key":"2019111807543451700_B18","doi-asserted-by":"crossref","first-page":"21191","DOI":"10.1016\/S0021-9258(17)31947-6","article-title":"An endothelial cell receptor for plasminogen\/tissue plasminogen activator. I. Identity with annexin II.","volume":"269","author":"Hajjar","year":"1994","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111807543451700_B19","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1073\/pnas.94.10.5302","article-title":"Acute leukemia with promyelocytic features in PML\/RARalpha transgenic mice.","volume":"94","author":"He","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2019111807543451700_B20","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/sj.onc.1209216","article-title":"Leukemia with distinct phenotypes in transgenic mice expressing PML\/RAR alpha, PLZF\/RAR alpha or NPM\/RAR alpha.","volume":"25","author":"Rego","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"2019111807543451700_B21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1590\/S0100-879X2006000500008","article-title":"Asynchronous expression of myeloid antigens in leukemic cells in a PML\/RARalpha transgenic mouse model.","volume":"39","author":"Santana","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"2019111807543451700_B22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-9560-3-12","article-title":"Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes.","volume":"3","author":"Sommeijer","year":"2005","journal-title":"Thromb J"},{"issue":"1","key":"2019111807543451700_B23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1172\/JCI19684","article-title":"Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.","volume":"113","author":"Ling","year":"2004","journal-title":"J Clin Invest"},{"issue":"12","key":"2019111807543451700_B24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/hh2401.101066","article-title":"Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery.","volume":"89","author":"Ishii","year":"2001","journal-title":"Circ Res"},{"key":"2019111807543451700_B25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1749-6632.2000.tb06321.x","article-title":"Annexin II and regulation of cell surface fibrinolysis.","volume":"902","author":"Hajjar","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"2019111807543451700_B26","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1074\/jbc.273.8.4790","article-title":"The role of annexin II tetramer in the activation of plasminogen.","volume":"273","author":"Kassam","year":"1998","journal-title":"J Biol Chem"},{"issue":"8655","key":"2019111807543451700_B27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(89)90181-5","article-title":"Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia.","volume":"2","author":"Avvisati","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"2019111807543451700_B28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000207938","article-title":"epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.","volume":"56","author":"Keane","year":"1976","journal-title":"Acta Haematol"},{"issue":"6","key":"2019111807543451700_B29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-105-6-873","article-title":"Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.","volume":"105","author":"Schwartz","year":"1986","journal-title":"Ann Intern Med"},{"issue":"4","key":"2019111807543451700_B30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2003-07-2462","article-title":"Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.","volume":"103","author":"Sanz","year":"2004","journal-title":"Blood"},{"issue":"7","key":"2019111807543451700_B31","first-page":"1113","article-title":"Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.","volume":"8","author":"Hashimoto","year":"1994","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/1\/207\/1355527\/zh802712000207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/1\/207\/1355527\/zh802712000207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T11:59:03Z","timestamp":1642075143000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/1\/207\/30149\/Methionineinduced-hyperhomocysteinemia-reverts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-347187","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}